BMJ:一例再生障碍性贫血,双眼急性无痛性视力下降

2016-02-27 MedSci MedSci原创

女性患者,患有再生障碍性贫血,双眼急性无痛性视力下降。 眼底检查显示,患者双眼视网膜静脉扩张,视网膜深浅层多个出血点、视网膜前出血,Roth斑点(中心白点网膜出血;箭头所指部位)。血红蛋白为30 g/L(参考值为120-158 g/L),白细胞总数3.5×109/L(3.5-9),血小板计数为16×109/L(165-415)。

女性患者,患有再生障碍性贫血,双眼急性无痛性视力下降。

眼底检查显示,患者双眼视网膜静脉扩张,视网膜深浅层多个出血点、视网膜前出血,Roth斑点(中心白点网膜出血;箭头所指部位)。血红蛋白为30 g/L(参考值为120-158 g/L),白细胞总数3.5×109/L(3.5-9),血小板计数为16×109/L(165-415)。




眼底多水平出血可见于贫血,尤其是在血小板减少症与再生障碍性贫血和白血病等疾病并存时。黄斑中心凹前的视网膜出血可引起急性视力丧失。

虽然视力的突然丧失非常让人担忧,但是推荐应先行进行眼底检查以避免不必要的检查。在原发性疾病的治疗后,出血自行停止,血红蛋白和血小板的水平改善后,视力通常会在1-2个月内得到改善。

原始出处:

Koushik Tripathy, Rohan Chawla. Anaemic retinopathy. BMJ 2016; 352 doi: http://dx.doi.org/10.1136/bmj.i1009 (Published 25 February 2016)Cite this as: BMJ 2016;352:i1009.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1847925, encodeId=1d69184e92506, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Mon Jan 16 12:43:00 CST 2017, time=2017-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76119, encodeId=0e51e611985, content=未曾见过,受教!, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160406/IMG570506F023DF05364.jpg, createdBy=f19f1695574, createdName=拯救我的未来, createdTime=Wed Apr 06 21:04:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66566, encodeId=772066566b8, content=get, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 15:07:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66236, encodeId=86c266236d6, content=谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Sun Feb 28 22:59:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66217, encodeId=519f6621ee0, content=眼睛。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2cee1686934, createdName=1de4ac4em35(暂无匿称), createdTime=Sun Feb 28 21:06:00 CST 2016, time=2016-02-28, status=1, ipAttribution=)]
    2017-01-16 gaoxiaoe
  2. [GetPortalCommentsPageByObjectIdResponse(id=1847925, encodeId=1d69184e92506, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Mon Jan 16 12:43:00 CST 2017, time=2017-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76119, encodeId=0e51e611985, content=未曾见过,受教!, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160406/IMG570506F023DF05364.jpg, createdBy=f19f1695574, createdName=拯救我的未来, createdTime=Wed Apr 06 21:04:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66566, encodeId=772066566b8, content=get, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 15:07:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66236, encodeId=86c266236d6, content=谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Sun Feb 28 22:59:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66217, encodeId=519f6621ee0, content=眼睛。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2cee1686934, createdName=1de4ac4em35(暂无匿称), createdTime=Sun Feb 28 21:06:00 CST 2016, time=2016-02-28, status=1, ipAttribution=)]
    2016-04-06 拯救我的未来

    未曾见过,受教!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1847925, encodeId=1d69184e92506, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Mon Jan 16 12:43:00 CST 2017, time=2017-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76119, encodeId=0e51e611985, content=未曾见过,受教!, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160406/IMG570506F023DF05364.jpg, createdBy=f19f1695574, createdName=拯救我的未来, createdTime=Wed Apr 06 21:04:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66566, encodeId=772066566b8, content=get, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 15:07:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66236, encodeId=86c266236d6, content=谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Sun Feb 28 22:59:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66217, encodeId=519f6621ee0, content=眼睛。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2cee1686934, createdName=1de4ac4em35(暂无匿称), createdTime=Sun Feb 28 21:06:00 CST 2016, time=2016-02-28, status=1, ipAttribution=)]
    2016-03-01 破风4392

    get

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1847925, encodeId=1d69184e92506, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Mon Jan 16 12:43:00 CST 2017, time=2017-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76119, encodeId=0e51e611985, content=未曾见过,受教!, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160406/IMG570506F023DF05364.jpg, createdBy=f19f1695574, createdName=拯救我的未来, createdTime=Wed Apr 06 21:04:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66566, encodeId=772066566b8, content=get, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 15:07:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66236, encodeId=86c266236d6, content=谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Sun Feb 28 22:59:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66217, encodeId=519f6621ee0, content=眼睛。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2cee1686934, createdName=1de4ac4em35(暂无匿称), createdTime=Sun Feb 28 21:06:00 CST 2016, time=2016-02-28, status=1, ipAttribution=)]
    2016-02-28 1de3b290m83(暂无匿称)

    谢了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1847925, encodeId=1d69184e92506, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Mon Jan 16 12:43:00 CST 2017, time=2017-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76119, encodeId=0e51e611985, content=未曾见过,受教!, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160406/IMG570506F023DF05364.jpg, createdBy=f19f1695574, createdName=拯救我的未来, createdTime=Wed Apr 06 21:04:00 CST 2016, time=2016-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66566, encodeId=772066566b8, content=get, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 15:07:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66236, encodeId=86c266236d6, content=谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Sun Feb 28 22:59:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66217, encodeId=519f6621ee0, content=眼睛。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2cee1686934, createdName=1de4ac4em35(暂无匿称), createdTime=Sun Feb 28 21:06:00 CST 2016, time=2016-02-28, status=1, ipAttribution=)]
    2016-02-28 1de4ac4em35(暂无匿称)

    眼睛。。。。

    0

相关资讯

JCO:重组人红细胞生成素(EPO)并不优于RBC输血

 由于癌症患者接受化疗导致骨髓抑制,贫血也就成了这些癌症患者经常出现的症状。早前的研究表明促红细胞生成素刺激试剂可以减少对血红细胞输血的需求,增加血红蛋白水平,改善由化疗导致贫血的癌症患者的生活质量,也有可能延长生存时间。研究人员开展了一项随机、非盲、多中心、非劣性的临床三期试验来评价重组人红细胞生成素(EPO)用于治疗转移性乳腺癌患者化疗导致的贫血。 血红蛋白低于11.0 g

JAMA:红细胞储存时间的长短与其携氧能力的关系

贫血儿童由于乳酸水平较高经常出现酸中毒。该研究的目的是确定输注长期保存的红细胞单位同储存时间较短的红细胞后,对减少严重贫血儿童血液中乳酸含量和改善脑组织氧饱和度的区别。研究表明,红细胞保存时间的长短对降低血乳酸水平并无明显区别。这些发现对治疗缺氧和乳酸酸中毒的贫血患儿有重要影响。

想知道进食水果对机体有何好处么?

萊檬是墨西哥、越南和泰国民众常常食用的一种柑橘类水果。它全年生长于热带气候条件下,通常比柠檬较小,且没柠檬那么酸。 研究人员试图深入谈及萊檬的营养功能及其对民众的健康有何益处,如何在日常饮食中加入更多的萊檬,同时探究萊檬对机体潜在的健康风险。 根据美国农业部国家营养数据库的统计显示,一个萊檬(约44克)包含11卡热量、4克碳水化合物(1克糖,不含纤维素),且不含有蛋白质,其维生素C含量约占人日常应

Am J Clin Nutr:孕妇贫血与不良妊娠结局

发展中国家贫血是导致孕产妇死亡和不良妊娠结局的原因之一。研究者检索PubMed、EMBASE、CINAHL等数据库上关于女性贫血和妊娠结局的文章进行系统回顾和荟萃分析,同时分析低收入和中收入国家妊娠结局的人口归因分数(PAF)。研究者将血红蛋白值<10或<11 g/dL,或者血细胞比容<33%或<34%定义为贫血组。使用meta回归和分层分析探究参与者特征对妊娠结局的影响。

JASN:透析患者补充维生素D不能改善贫血症状

根据即将出现在美国肾脏病杂志JASN的一项研究,补充维生素D不能改善血液透析患者的贫血状况。营养维生素D在体内,骨外具有许多功能,维生素D缺乏牵涉到很多疾病,从心血管疾病到癌症。初步证据表明,营养补充维生素D可以通过增加血细胞产生,红细胞生成对透析患者有益。由于许多肾功能不全的患者会发生贫血或红细胞水平较低,补充维生素D将对这些人有益。在这项最大规模的检测维生素D对透析患者的影响的随机临床试验中,

孕期服用ω-3补充剂可预防新生儿出生缺陷和铁缺乏

既往研究证明,孕产妇补充DHA可提高胎儿的铁代谢。格拉纳达大学和伦敦大学国王学院的研究人员联合母婴医院联合进行这项实验。研究结果表明,孕产期补充DHA,可有助于胎儿大脑发育,增强新生儿铁代谢,预防铁缺乏和新生儿认知缺陷。研究结果发表在Functional Foods magazine。 研究人员选择了110名健康且在产科医院分娩的产妇。研究人员在孕妇孕6个月时开始采取随机、双盲的营养评估。第一组有